Helena Schnell

Helena Schnell is an accomplished scientist with extensive experience in protein therapeutics and research on proteasome function and stress responses. Currently serving as Associate Principal Scientist at Odyssey Therapeutics since May 2022, Helena has previously held positions as a Predoctoral Research Fellow at Brigham and Women's Hospital and Harvard Medical School, focusing on structural and functional studies of the proteasome. Helena's leadership experience includes co-presidency at INet-NYC, where strategic planning and event organization were key responsibilities. Helena's academic background includes a Ph.D. in Biological Sciences from Ulm University and multiple degrees in Pharmaceutical Biotechnology and Technical Biology.